Posted on 12/9/20
Sigilon Therapeutics Closes of Upsized IPO
CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (Nasdaq: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through . . .
Posted on 12/9/20
Planet Fitness In South Florida Welcomes Gym Members Of Nearby Fitness Centers To The Judgment Free Zone
Enabling individuals to keep their health and wellness a priority Planet Fitness, Inc., one of the largest and fastest-growing global franchisors and operators of fitness centers . . .
Posted on 12/9/20
Neuronetics Amendment of Credit Facility with Solar Capital Partners
MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that . . .
Posted on 12/9/20
Thermo Fisher Doubles Global Footprint For Drug Development And Commercial Manufacturing
Thermo Fisher Scientific (NYSE:TMO) further expanded its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and . . .
Posted on 12/9/20
Thoma Bravo Acquires AxiomSL
Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, today announced the completion of its acquisition of AxiomSL
Posted on 12/9/20
ADMA Biologics Enters Into $100 Million Credit Facility
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing . . .
Posted on 12/9/20
Pfizer's Coronavirus Vaccine Is 52.4% Effective After First Dose
On Monday morning, the FDA published briefing documents for an upcoming meeting of a panel of independent medical experts who will weigh in on data from . . .
Posted on 12/9/20
Why Novavax Stock Crushed It in November
What happenedShares of the COVID-19 vaccine developer Novavax (NASDAQ:NVAX) jumped by a healthy 73% during the month of November, according to data from S&P Global Market . . .
Posted on 12/9/20
Why Shares of iBio, Marinus Pharmaceuticals, and Arcturus Therapeutics All Crashed on Tuesday
What happenedOn Tuesday, shares of up-and-coming biotechs Marinus Pharmaceuticals (NASDAQ:MRNS), iBio (NYSEMKT:IBIO), and Arcturus Therapeutics Holdings (NASDAQ:ARCT) fell by 12%, 13%, and 19%, respectively.One common catalyst . . .
Posted on 12/9/20
iBio: Another Vaccine Effort Unlikely To Materialize
SummaryiBio (IBIO) is a Texas-based company whose stock is up 496% year to date on investor optimism about its COVID-19 vaccine efforts.IBIO claims to have been . . .
Posted on 12/9/20
iSpecimen Seeks $20 Million In U.S. IPO Plan
SummaryiSpecimen has filed to raise $20 million in an IPO.The firm operates a human biospecimen online marketplace.ISPN has grown from a small revenue base and operates . . .
Posted on 12/8/20
Curis Announces Proposed Public Offering of Common Stock
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced its intention to offer and . . .
Posted on 12/8/20
Neurotrope Completes Independent Spin-off of Neurotrope Bioscience and is Renamed Synaptogenix
Synaptogenix, Inc. (OTC: SNPX), formerly Neurotrope Bioscience, Inc., today announced the successful spin-off of substantially all of the legacy assets and liabilities of Neurotrope, Inc. into . . .
Posted on 12/8/20
Forma Therapeutics Launches Proposed Public Offering
WATERTOWN, MA--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it has launched a . . .
Posted on 12/8/20
Syros Closes $90.5 Million Strategic Financing
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, announced today that it has closed a previously announced private . . .
Posted on 12/8/20
Maryland Reports 50 New COVID-19 Deaths, Highest Daily Death Total Since May
Maryland on Tuesday reported 50 new coronavirus-related deaths, the highest number of COVID-19 fatalities reported in one day since May.The state has reported fewer than 50 . . .
Posted on 12/8/20
Peak Physical Therapy & Sports Performance Promotes Samantha Meade to Lead Physical Therapy Aide for the Company
Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive
Posted on 12/8/20
Howard County General Hospital Holds ‘Managing Joint Pain’ Seminar
Howard County General Hospital will hold “Managing Joint Pain: When is it Time to Consider Joint Replacement?” virtually on Friday, Jan. 15, 2021, from noon to . . .
Posted on 12/8/20
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2021
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020.First quarter 2021 net sales were $297.0M, up 15.5% compared . . .
Posted on 12/8/20
Marinus Pharmaceuticals Prices of $70 Million Public Offering of Common Stock
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing . . .
Posted on 12/8/20
Trinity Life Sciences Acquires BluePrint Research Group
Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity
Posted on 12/8/20
Pear Therapeutics Closes $80M Series D Financing
Pear Therapeutics, Inc., today announced that it has successfully closed an $80 million Series D financing led by SoftBank Vision Fund 21 with participation
Posted on 12/8/20
With Slow Health Benefit Cost Growth In 2020, Employers Plan To Invest In More Support For Employees, Says Mercer
Total health benefit cost rose 3.4% on average in 2020 (Fig. 1), reaching $13,674 per employee among all US employer health plan sponsors with 50 or . . .
Posted on 12/8/20
Vigil Neuroscience Launches $50 Million Series A
Vigil Neuroscience, a new biotechnology company harnessing the power of microglia for the treatment of neurodegenerative diseases, launched today with $50 million Series A financing.
Posted on 12/8/20
Is Novavax Still a Buy After Jumping 3,000%?
Novavax (NASDAQ:NVAX) has jumped from a price of $4 a share back in January to $128 a share in December. That's a huge 3,000% gain for . . .

